Reduction of experimental diabetic vascular leakage by delivery of angiostatin with a recombinant adeno-associated virus vector

PURPOSE: To evaluate the efficacy of recombinant adeno-associated virus (rAAV) vector expressing mouse angiostatin (Kringle domains 1 to 4) in reducing retinal vascular leakage in an experimental diabetic rat model. METHODS: rAAV-angiostatin was delivered by intravitreal injection to the right eyes...

Descripción completa

Detalles Bibliográficos
Autores principales: Shyong, Mong-Ping, Lee, Fenq-Lih, Kuo, Ping-Chang, Wu, Ai-Ching, Cheng, Huey-Chung, Chen, Show-Li, Tung, Tao-Hsin, Tsao, Yeou-Ping
Formato: Texto
Lenguaje:English
Publicado: Molecular Vision 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2533034/
https://www.ncbi.nlm.nih.gov/pubmed/17293777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2533034/
https://www.ncbi.nlm.nih.gov/pubmed/17293777

Ejemplares similares